Monoclonal antibodies identify a CEA cross-reacting antigen of 95 kD (NCA-95) distinct in antigenity and tissue distribution from the previously described NCA of 55 kD - Buchegger, F; Schreyer, M; Carrel, S (Int J Cancer, 1984)